title: The effect of a case management intervention on drug treatment entry among treatment-seeking injection drug users with and without comorbid antisocial personality disorder.
abstract: We examined the effect of a case management intervention on drug treatment entry among injection drug users (IDUs) with and without comorbid antisocial personality disorder (ASPD). Injection drug users attending the Baltimore Needle Exchange Program who sought and were granted referrals to opioid agonist treatment were randomized to receive a strengths-based case management intervention or passive referral. Of 162 IDUs, 22.8% met the DSM-IV criteria for ASPD. Compared to those without ASPD, IDUs with comorbid ASPD who spent 25 or more minutes with their case manager prior to their treatment entry date were 3.51 times more likely to enter treatment than those receiving less than 5 min, adjusting for intervention status, race, and treatment site (95% confidence interval 1.04-11.89). Providing case management services to IDUs with comorbid ASPD may facilitate treatment entry and reduce the negative consequences of drug abuse.
authors.affiliation: Center on Drug and Alcohol Research, University of Kentucky College of Medicine, Lexington, KY, USA. jennifer.havens@uky.edu
authors.forename: Jennifer R
authors.initials: JR
authors.lastname: Havens
authors.forename: Llewellyn J
authors.initials: LJ
authors.lastname: Cornelius
authors.forename: Erin P
authors.initials: EP
authors.lastname: Ricketts
authors.forename: Carl A
authors.initials: CA
authors.lastname: Latkin
authors.forename: David
authors.initials: D
authors.lastname: Bishai
authors.forename: Jacqueline J
authors.initials: JJ
authors.lastname: Lloyd
authors.forename: Steven
authors.initials: S
authors.lastname: Huettner
authors.forename: Steffanie A
authors.initials: SA
authors.lastname: Strathdee
mesh_terms: D000328:Adult; D000987:Antisocial Personality Disorder / Q000150:complications* / Q000517:prevention & control; D015142:Baltimore / Q000453:epidemiology; D019090:Case Management; D017831:Diagnosis, Dual (Psychiatry); D005260:Female; D006801:Humans; D008297:Male; D015999:Multivariate Analysis; D009294:Narcotics / Q000627:therapeutic use; D018671:Needle-Exchange Programs / Q000706:statistics & numerical data*; D009293:Opioid-Related Disorders / Q000150:complications / Q000534:rehabilitation*; D011957:Receptors, Opioid / Q000819:agonists; D012309:Risk-Taking; D016320:Substance Abuse Treatment Centers / Q000706:statistics & numerical data*; D015819:Substance Abuse, Intravenous / Q000150:complications / Q000534:rehabilitation*; D013997:Time Factors; D019037:Urban Health Services
chemical_list: D009294:Narcotics; D011957:Receptors, Opioid